Post-translational modifications and regulation of the RAS superfamily of GTPases as anticancer targets. [electronic resource]
- Nature reviews. Drug discovery Jul 2007
- 541-55 p. digital
Publication Type: Journal Article; Review
1474-1776
10.1038/nrd2221 doi
Animals Antineoplastic Agents--pharmacology Clinical Trials as Topic Farnesyltranstransferase--antagonists & inhibitors Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors--therapeutic use Neoplasms--drug therapy Protein Prenylation--drug effects Protein Processing, Post-Translational ras Proteins--metabolism